Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 261
interventional 227
Observational 32
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 120
Drug|placebo 46
Biological|placebo 22
Biological 16
Drug|Other 5
Device|placebo 4
Device 3
Biological|Drug|placebo 2
Other 2
Behavioral|Other 1
Biological|Drug 1
Biological|Other 1
Device|Drug|Other 1
Device|Procedure 1
Dietary Supplement|Other|placebo 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 82
NA 35
Germany 14
Spain 11
Canada 10
Japan 9
Brazil 4
France 4
India 3
Korea, Republic of 3
Mexico 3
Poland 3
Belgium 2
Bulgaria|Czech Republic|Germany|Hungary|Lithuania|Netherlands|Slovakia 2
China 2
Italy 2
Singapore 2
Switzerland 2
Taiwan 2
United States|India 2
Australia 1
Australia|Germany|Sweden 1
Austria 1
Austria|Belgium|Germany|Netherlands|Spain 1
Austria|China 1
Belgium|Czech Republic|Germany|Poland|Slovakia 1
Belgium|Germany|Netherlands|Poland 1
Czech Republic|Denmark|Estonia|Finland|France|Germany|Latvia|Lithuania|Poland|Slovakia|Sweden 1
Czech Republic|Germany|Poland 1
Denmark 1
Estonia|Germany|Greece|Latvia|Lithuania|Romania 1
Finland 1
Germany|Lithuania|Poland 1
Germany|Poland 1
Germany|Poland|Sweden 1
Israel 1
Portugal|Spain 1
South Africa 1
Sweden 1
Thailand 1
United Kingdom 1
United States|Australia|Austria|Canada|Estonia|France|Hungary|Israel|Italy|Poland|Puerto Rico|South Africa|Spain 1
United States|Australia|Canada|Czech Republic|France|Germany|India|Israel|Italy|New Zealand|Spain|United Kingdom 1
United States|Belgium|Canada|Czechia|Germany|Hungary|Poland|Russian Federation|Slovakia 1
United States|Brazil 1
United States|Brazil|India|Sri Lanka 1
United States|Canada 1
United States|Canada|France|Germany|Italy|Netherlands|South Africa|Spain 1
United States|Germany 1
United States|Italy 1

Sites per Study

Site_count Study_Count
1 159
2 12
3 6
4 3
5 3
6 7
7 3
8 6
10 2
11 2
12 2
13 1
14 2
16 1
17 1
20 1
21 1
23 1
26 1
32 1
35 1
36 1
39 2
40 2
58 1
60 1
81 1
98 1
118 1
163 1

Phase

Phase Study_Count
Phase 3 83
Phase 2 63
Phase 4 37
N/A 14
Phase 1 12
Phase 2/Phase 3 12
Phase 1/Phase 2 5
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 29
2 108
3 32
4 28
5 10
6 4
9 2
NA 14

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 7 14.00000 24.00 21.0 16.0000 12.00 1.0000 11.00000
1st Qu. 7 30.75000 29.25 36.0 68.0000 105.50 110.0000 23.00000
Median 7 41.00000 44.00 52.0 132.0000 237.50 250.0000 47.00000
Mean 7 64.57143 41.00 45.8 177.7778 326.25 363.8171 95.08108
3rd Qu. 7 78.00000 48.50 54.0 230.0000 575.00 516.5000 137.00000
Max. 7 186.00000 72.00 66.0 805.0000 784.00 1501.0000 628.00000

Trial Group Type

group_type Group_Count
Experimental 271
Placebo Comparator 146
Active Comparator 114
NA 14
Other 8
No Intervention 3
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 175
Single Group Assignment 37
Crossover Assignment 12
NA 2
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 191
Prevention 11
NA 11
Diagnostic 7
Screening 3
Basic Science 2
Other 2

Observational Studies

Studies by Country

Country Study_Count
United States 8
Germany 3
Korea, Republic of 3
NA 3
Spain 3
Canada 2
China 2
France 2
Italy 2
Brazil 1
Israel 1
Netherlands 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 26
10 1
13 1
15 1
19 1
25 1
81 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 100.0000
Median 240.5000
Mean 627.4062
3rd Qu 610.7500
Max 3423.0000

Observation Model

observational_model Study_Count
Cohort 17
Case-Control 3
Case-Only 3
Ecologic or Community 3
NA 3
Case Control 2
Other 1

Time Perspective

time_perspective Study_Count
Prospective 18
Cross-Sectional 7
Retrospective 4
NA 3

Registries

Studies by Country

Country Study_Count
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
2 1
14 1

Enrollment Metrics

Measure Registries
Min 215
1st Qu 320
Median 425
Mean 425
3rd Qu 530
Max 635

Registry Model

observational_model Study_Count
Case-Crossover 1
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
1 Month 1
1 Year 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03365648 Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics https://ClinicalTrials.gov/show/NCT03365648 Completed NTC srl 2018-07-04
NCT03379311 A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03379311 Completed Allakos, Inc. 2019-08-08
NCT03375775 Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children https://ClinicalTrials.gov/show/NCT03375775 Active, not recruiting Karolinska Institutet 2022-01-31
NCT03368339 Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03368339 Completed Realm Therapeutics, Inc. 2018-01-21
NCT03320434 Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03320434 Completed ORA, Inc. 2018-02-16
NCT03231969 A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model https://ClinicalTrials.gov/show/NCT03231969 Completed Faes Farma, S.A. 2017-10-11
NCT03186755 Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03186755 Recruiting St. Justine’s Hospital 2020-12-31
NCT03012165 A Study of ADX-102 in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03012165 Completed Aldeyra Therapeutics, Inc. 2017-05-31
NCT03004924 Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo https://ClinicalTrials.gov/show/NCT03004924 Completed Shire 2018-10-01
NCT02988882 OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02988882 Completed Ocular Therapeutix, Inc. 2016-04-30
NCT02980523 Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) https://ClinicalTrials.gov/show/NCT02980523 Completed Laboratorios Sophia S.A de C.V. 2016-06-30
NCT02978183 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02978183 Completed Noveome Biotherapeutics, formerly Stemnion 2017-02-28
NCT02881879 Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites https://ClinicalTrials.gov/show/NCT02881879 Completed Roxall Medicina España S.A 2017-09-30
NCT02661854 Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy https://ClinicalTrials.gov/show/NCT02661854 Active, not recruiting Inmunotek S.L. 2020-07-31
NCT02654223 Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy https://ClinicalTrials.gov/show/NCT02654223 Recruiting Inmunotek S.L. 2020-12-31
NCT02506998 Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts https://ClinicalTrials.gov/show/NCT02506998 Completed National Polytechnic Institute, Mexico 2015-01-31
NCT02503956 Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients https://ClinicalTrials.gov/show/NCT02503956 Completed Rabin Medical Center 2016-07-22
NCT02492321 A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02492321 Completed Eleven Biotherapeutics 2015-11-30
NCT02477917 A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica https://ClinicalTrials.gov/show/NCT02477917 Completed Roxall Medicina España S.A 2016-03-31
NCT02472223 Reducing Adenoviral Patient Infected Days https://ClinicalTrials.gov/show/NCT02472223 Recruiting Washington University School of Medicine 2020-01-31
NCT02445326 OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02445326 Completed Ocular Therapeutix, Inc. 2015-08-31
NCT02432807 Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT02432807 Completed Kurobe LLC 2018-05-31
NCT02340130 Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma https://ClinicalTrials.gov/show/NCT02340130 Completed Laboratorios Leti, S.L. 2018-05-31
NCT02322216 Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects https://ClinicalTrials.gov/show/NCT02322216 Completed Alcon Research 2015-10-31
NCT02308501 A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy https://ClinicalTrials.gov/show/NCT02308501 Completed ORA, Inc. 2015-02-28
NCT02271009 Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC https://ClinicalTrials.gov/show/NCT02271009 Completed Anergis 2015-05-31
NCT02251613 Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan https://ClinicalTrials.gov/show/NCT02251613 Completed Alcon Research 2014-01-31
NCT02231307 SUBLIVAC FIX Birch Phase III Short-term Efficacy https://ClinicalTrials.gov/show/NCT02231307 Completed HAL Allergy 2015-07-31
NCT02161146 AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02161146 Completed Allergan 2014-12-20
NCT02150343 Phase II HDM-SPIRE Safety and Efficacy Study https://ClinicalTrials.gov/show/NCT02150343 Completed Circassia Limited 2017-04-13
NCT02148744 Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02148744 Completed Xencor, Inc. 2015-09-21
NCT02132169 A Multi-Center Study Evaluating the Safety of AC-170 0.24% https://ClinicalTrials.gov/show/NCT02132169 Completed Aciex Therapeutics, Inc. 2014-10-31
NCT02082899 A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) https://ClinicalTrials.gov/show/NCT02082899 Completed Eleven Biotherapeutics 2014-06-30
NCT02082262 AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02082262 Completed Allergan 2014-07-31
NCT02079649 Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02079649 Completed Alcon Research 2014-07-31
NCT02062905 OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02062905 Completed Ocular Therapeutix, Inc. 2014-08-31
NCT01294969 Patient Perception Study for AL-4943A https://ClinicalTrials.gov/show/NCT01294969 Completed Alcon Research 2011-10-31
NCT01289431 Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01289431 Completed Bausch & Lomb Incorporated 2011-04-30
NCT01282138 Assessment of Alcon’s Ocular Image Quantification System https://ClinicalTrials.gov/show/NCT01282138 Completed Alcon Research 2011-03-31
NCT01275105 A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC) https://ClinicalTrials.gov/show/NCT01275105 Completed Eye Therapies, LLC 2011-03-31
NCT01272089 A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01272089 Completed Alcon Research 2011-12-31
NCT01977443 Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) https://ClinicalTrials.gov/show/NCT01977443 Completed Adenovir Pharma AB 2016-09-30
NCT01949441 ToleroMune House Dust Mite (HDM) Tolerability Study https://ClinicalTrials.gov/show/NCT01949441 Completed Circassia Limited 2014-05-31
NCT01921257 Paediatric Safety Study in Cat-PAD https://ClinicalTrials.gov/show/NCT01921257 Completed Circassia Limited 2015-12-31
NCT01902992 Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch https://ClinicalTrials.gov/show/NCT01902992 Completed Novartis 2012-07-31
NCT01881113 A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle https://ClinicalTrials.gov/show/NCT01881113 Completed Aciex Therapeutics, Inc. 2013-10-31
NCT01877694 Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT01877694 Completed NovaBay Pharmaceuticals, Inc. 2014-12-31
NCT01852825 MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) https://ClinicalTrials.gov/show/NCT01852825 Completed Merck Sharp & Dohme Corp. 2015-07-20
NCT01799863 Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis https://ClinicalTrials.gov/show/NCT01799863 Completed Fundação Altino Ventura 2013-03-31
NCT01754766 AGN-229666 for the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01754766 Completed Allergan 2013-01-31
NCT01743027 Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01743027 Completed Alcon Research 2013-07-31
NCT01740284 A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine https://ClinicalTrials.gov/show/NCT01740284 Completed ALK-Abelló A/S 2009-01-31
NCT01732757 A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01732757 Completed Allergan 2012-12-31
NCT01731249 Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT01731249 Completed Stallergenes Greer 2012-07-31
NCT01730872 Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model https://ClinicalTrials.gov/show/NCT01730872 Completed ORA, Inc. 2012-12-31
NCT01698814 A Six-Week Safety Study of an Investigational Ophthalmic Solution https://ClinicalTrials.gov/show/NCT01698814 Completed Alcon Research 2013-01-31
NCT01697969 Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients https://ClinicalTrials.gov/show/NCT01697969 Completed Alcon Research 2013-07-31
NCT01694836 Depigoid Birch 5000 Longterm Study in Adults and Adolescents https://ClinicalTrials.gov/show/NCT01694836 Completed Leti Pharma GmbH 2018-07-30
NCT01685242 A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle https://ClinicalTrials.gov/show/NCT01685242 Completed Aciex Therapeutics, Inc. 2012-11-30
NCT01682070 SUBLIVAC FIX Phleum Pratense DT/DRF https://ClinicalTrials.gov/show/NCT01682070 Completed HAL Allergy 2013-05-31
NCT01639846 Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01639846 Completed C.T. Development America, Inc. 2012-08-31
NCT01639768 SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding https://ClinicalTrials.gov/show/NCT01639768 Completed HAL Allergy 2013-03-31
NCT01620762 Phase III Cat-PAD Study https://ClinicalTrials.gov/show/NCT01620762 Completed Circassia Limited 2016-06-30
NCT01573910 An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients https://ClinicalTrials.gov/show/NCT01573910 Completed Alcon Research 2014-04-30
NCT01569191 Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01569191 Completed Aston University 2012-11-30
NCT01567306 Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense https://ClinicalTrials.gov/show/NCT01567306 Completed Roxall Medicina España S.A 2013-04-30
NCT01564017 Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract https://ClinicalTrials.gov/show/NCT01564017 Completed Roxall Medicina España S.A 2013-05-31
NCT01561521 An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01561521 Completed Akorn, Inc. 2012-04-30
NCT01554956 Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients https://ClinicalTrials.gov/show/NCT01554956 Active, not recruiting Kedrion S.p.A. 2014-04-30
NCT01551056 A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) https://ClinicalTrials.gov/show/NCT01551056 Completed Aciex Therapeutics, Inc. 2012-06-30
NCT01534195 Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model https://ClinicalTrials.gov/show/NCT01534195 Completed ORA, Inc. 2012-02-29
NCT01533480 A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis https://ClinicalTrials.gov/show/NCT01533480 Completed Lifelong Vision Foundation 2014-12-31
NCT01532336 Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis https://ClinicalTrials.gov/show/NCT01532336 Completed NovaBay Pharmaceuticals, Inc. 2014-05-31
NCT01490411 Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT01490411 Completed Allergopharma GmbH & Co. KG 2011-04-30
NCT01489020 Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT) https://ClinicalTrials.gov/show/NCT01489020 Completed Roxall Medicina España S.A 2011-07-31
NCT01481519 A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis https://ClinicalTrials.gov/show/NCT01481519 Completed University of Campinas, Brazil 2012-12-31
NCT01479374 Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model https://ClinicalTrials.gov/show/NCT01479374 Completed Alcon Research 2012-03-31
NCT01471184 The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo https://ClinicalTrials.gov/show/NCT01471184 Completed Bitop AG 2010-03-31
NCT01470664 FST-100 in the Treatment of Acute Adenoviral Conjunctivitis https://ClinicalTrials.gov/show/NCT01470664 Completed Shire 2014-05-31
NCT01470118 A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01470118 Completed Allergan 2011-12-31
NCT01461954 FST-100 in the Treatment of Acute Viral Conjunctivitis https://ClinicalTrials.gov/show/NCT01461954 Completed Shire 2014-02-28
NCT01443442 Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01443442 Completed Southern California College of Optometry 2012-09-30
NCT01439815 An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo https://ClinicalTrials.gov/show/NCT01439815 Completed ORA, Inc. 2011-10-31
NCT01438463 PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT01438463 Completed HAL Allergy 2013-05-31
NCT01437982 A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% https://ClinicalTrials.gov/show/NCT01437982 Completed Bausch & Lomb Incorporated 2015-10-19
NCT01435460 Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC) https://ClinicalTrials.gov/show/NCT01435460 Completed Bausch & Lomb Incorporated 2011-04-30
NCT01433510 Tolerability of Grazax in Patients With Hayfever in Real Life Settings https://ClinicalTrials.gov/show/NCT01433510 Completed ALK-Abelló A/S 2010-10-31
NCT01425788 Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense https://ClinicalTrials.gov/show/NCT01425788 Completed ALK-Abelló A/S 2011-11-30
NCT01385371 A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) https://ClinicalTrials.gov/show/NCT01385371 Completed ALK-Abelló A/S 2012-08-31
NCT01363713 A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01363713 Completed Santen Pharmaceutical Co., Ltd. 2012-09-30
NCT01363700 Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01363700 Completed Santen Pharmaceutical Co., Ltd. 2012-06-30
NCT01353755 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma https://ClinicalTrials.gov/show/NCT01353755 Completed Allergopharma GmbH & Co. KG 2012-08-31
NCT01349452 Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis https://ClinicalTrials.gov/show/NCT01349452 Completed Federal University of São Paulo 2009-12-31
NCT01346371 The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer https://ClinicalTrials.gov/show/NCT01346371 Completed Minnesota Eye Consultants, P.A. 2012-08-31
NCT01344083 Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01344083 Completed Laboratoires Thea 2012-02-29
NCT01342601 Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents https://ClinicalTrials.gov/show/NCT01342601 Completed Bitop AG 2011-09-30
NCT01332188 Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model https://ClinicalTrials.gov/show/NCT01332188 Completed Aciex Therapeutics, Inc. 2011-06-30
NCT01326858 Safety and Comfort of AL-4943A Ophthalmic Solution https://ClinicalTrials.gov/show/NCT01326858 Completed Alcon Research 2011-06-30
NCT01320553 Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01320553 Completed Sun Pharma Advanced Research Company Limited 2011-08-31
NCT03616899 Safety and Efficacy of KPI-121 in Subjects With DED https://ClinicalTrials.gov/show/NCT03616899 Completed Kala Pharmaceuticals, Inc. 2020-02-05
NCT04275232 Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis https://ClinicalTrials.gov/show/NCT04275232 Enrolling by invitation Memorial University of Newfoundland 2022-05-31
NCT04207736 The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. https://ClinicalTrials.gov/show/NCT04207736 Recruiting Aldeyra Therapeutics, Inc. 2020-09-30
NCT04176185 A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber https://ClinicalTrials.gov/show/NCT04176185 Recruiting ALK-Abelló A/S 2020-10-15
NCT04050865 A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT04050865 Active, not recruiting Ocular Therapeutix, Inc. 2020-02-29
NCT03987178 Microbiologic Alterations of the Conjunctiva of Hot Tub-soaking Ophthalmologists https://ClinicalTrials.gov/show/NCT03987178 Recruiting University of California, San Francisco 2020-05-08
NCT03861728 Viral Conjunctivitis Treatment Study https://ClinicalTrials.gov/show/NCT03861728 Recruiting University of Miami 2021-06-01
NCT03856645 OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis https://ClinicalTrials.gov/show/NCT03856645 Recruiting Okogen 2020-12-31
NCT03839069 Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis https://ClinicalTrials.gov/show/NCT03839069 Recruiting National Taiwan University Hospital 2020-12-31
NCT03758456 HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human https://ClinicalTrials.gov/show/NCT03758456 Completed HAL Allergy 2019-05-17
NCT03755557 Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray https://ClinicalTrials.gov/show/NCT03755557 Completed Marinomed Biotech AG 2019-04-05
NCT03749317 Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis https://ClinicalTrials.gov/show/NCT03749317 Recruiting IVIEW Therapeutics Inc. 2020-11-30
NCT03709121 A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber https://ClinicalTrials.gov/show/NCT03709121 Completed Aldeyra Therapeutics, Inc. 2019-03-20
NCT03696342 Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. https://ClinicalTrials.gov/show/NCT03696342 Recruiting Laboratorios Sophia S.A de C.V. 2020-01-31
NCT03682965 Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study https://ClinicalTrials.gov/show/NCT03682965 Completed Texan Allergy & Sinus Center 2019-03-06
NCT03660878 A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03660878 Completed Aldeyra Therapeutics, Inc. 2019-11-19
NCT03519516 Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects https://ClinicalTrials.gov/show/NCT03519516 Completed Laboratorios Sophia S.A de C.V. 2018-05-25
NCT03494504 ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03494504 Completed Aldeyra Therapeutics, Inc. 2018-11-05
NCT03489941 A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle https://ClinicalTrials.gov/show/NCT03489941 Completed EyeMax, LLC 2018-04-29
NCT03479307 A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model https://ClinicalTrials.gov/show/NCT03479307 Completed Faes Farma, S.A. 2018-08-09
NCT01258309 Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01258309 Completed Allergan 2011-01-31
NCT01203540 Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients https://ClinicalTrials.gov/show/NCT01203540 Completed Laboratoires Thea NA
NCT01179412 Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine https://ClinicalTrials.gov/show/NCT01179412 Completed Mahidol University 2009-12-31
NCT01178762 The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis https://ClinicalTrials.gov/show/NCT01178762 Completed National Taiwan University Hospital 2007-11-30
NCT01175590 Safety of Besivanceâ„¢ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle https://ClinicalTrials.gov/show/NCT01175590 Completed Bausch & Lomb Incorporated 2011-12-31
NCT01174823 Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients https://ClinicalTrials.gov/show/NCT01174823 Completed Bausch & Lomb Incorporated 2010-10-31
NCT01159769 Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01159769 Completed Alcon Research 2010-08-31
NCT01159015 Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01159015 Completed Bausch & Lomb Incorporated 2010-09-30
NCT01155999 Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. https://ClinicalTrials.gov/show/NCT01155999 Completed Laboratoires Thea 2011-02-28
NCT01144429 Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma https://ClinicalTrials.gov/show/NCT01144429 Completed Leti Pharma GmbH 2011-02-28
NCT01134328 Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CACâ„¢ Model https://ClinicalTrials.gov/show/NCT01134328 Completed Aciex Therapeutics, Inc. 2010-07-31
NCT01120132 Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01120132 Completed Fovea Pharmaceuticals SA 2010-08-31
NCT01119287 Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01119287 Completed Alcon Research 2010-09-30
NCT01111279 Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT01111279 Completed BioTech Tools S.A. 2010-09-30
NCT01109485 Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients https://ClinicalTrials.gov/show/NCT01109485 Completed Alcon Research 2011-07-31
NCT01107405 Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge https://ClinicalTrials.gov/show/NCT01107405 Completed Bausch & Lomb Incorporated 2010-05-31
NCT01081574 Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) https://ClinicalTrials.gov/show/NCT01081574 Completed Faes Farma, S.A. 2012-06-30
NCT01037179 An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT01037179 Completed Alcon Research 2010-05-31
NCT01028027 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis https://ClinicalTrials.gov/show/NCT01028027 Completed Bausch & Lomb Incorporated 2010-02-28
NCT01013259 Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT01013259 Completed Charite University, Berlin, Germany 2009-09-30
NCT01001091 AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation https://ClinicalTrials.gov/show/NCT01001091 Completed Alcon Research 2010-04-30
NCT00987272 Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects https://ClinicalTrials.gov/show/NCT00987272 Completed Alcon Research 2009-11-30
NCT00978029 Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) https://ClinicalTrials.gov/show/NCT00978029 Completed ALK-Abelló A/S 2010-02-28
NCT00973453 Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients https://ClinicalTrials.gov/show/NCT00973453 Completed HAL Allergy 2010-08-31
NCT00972777 Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00972777 Completed Bausch & Lomb Incorporated 2010-10-31
NCT00921895 A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis https://ClinicalTrials.gov/show/NCT00921895 Completed Rapid Pathogen Screening 2011-06-30
NCT00917488 Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). https://ClinicalTrials.gov/show/NCT00917488 Completed Laboratorios Leti, S.L. 2010-05-31
NCT00891436 Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms https://ClinicalTrials.gov/show/NCT00891436 Completed Rush University Medical Center 2009-07-31
NCT00889330 Safety and Efficacy Study of a Eye Drop for Eye Allergy https://ClinicalTrials.gov/show/NCT00889330 Completed Vistakon Pharmaceuticals 2009-05-31
NCT00889252 Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers https://ClinicalTrials.gov/show/NCT00889252 Completed Vistakon Pharmaceuticals 2009-07-31
NCT00884585 Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis https://ClinicalTrials.gov/show/NCT00884585 Completed Allergan 2010-10-31
NCT00882687 Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00882687 Completed Shire 2009-05-31
NCT00857779 Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients https://ClinicalTrials.gov/show/NCT00857779 Completed ALK-Abelló A/S 2009-08-31
NCT03878628 Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease https://ClinicalTrials.gov/show/NCT03878628 Recruiting Rigshospitalet, Denmark 2020-04-30
NCT00836485 Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00836485 Completed Senju USA, Inc. 2009-03-31
NCT00833495 Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation https://ClinicalTrials.gov/show/NCT00833495 Completed Fovea Pharmaceuticals SA 2009-03-31
NCT00833066 Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT00833066 Completed BioTech Tools S.A. 2009-10-31
NCT00824447 Long-term Efficacy and Safety Study With Oralgen Grass Pollen https://ClinicalTrials.gov/show/NCT00824447 Completed Artu Biologicals 2008-08-31
NCT01634958 Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma https://ClinicalTrials.gov/show/NCT01634958 Completed Leti Pharma GmbH 2013-04-30
NCT02578914 A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT02578914 Completed Aldeyra Therapeutics, Inc. 2015-12-31
NCT00783198 Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) https://ClinicalTrials.gov/show/NCT00783198 Completed ALK-Abelló A/S 2011-05-31
NCT00775658 Olopatadine Eye Drops and Allergy Skin Testing https://ClinicalTrials.gov/show/NCT00775658 Completed Vanderbilt University Medical Center 2008-06-30
NCT00770315 Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) https://ClinicalTrials.gov/show/NCT00770315 Completed ALK-Abelló A/S 2011-05-31
NCT00770133 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. https://ClinicalTrials.gov/show/NCT00770133 Completed Bausch & Lomb Incorporated 2010-04-30
NCT00769886 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. https://ClinicalTrials.gov/show/NCT00769886 Completed Bausch & Lomb Incorporated 2008-12-31
NCT00759148 Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00759148 Completed Alcon Research 2010-03-31
NCT00732446 Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis https://ClinicalTrials.gov/show/NCT00732446 Completed Federal University of São Paulo 2008-12-31
NCT00718744 Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units https://ClinicalTrials.gov/show/NCT00718744 Completed Laboratorios Leti, S.L. 2008-11-30
NCT00705159 Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis https://ClinicalTrials.gov/show/NCT00705159 Completed Bausch & Lomb Incorporated 2010-03-31
NCT00689078 Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model https://ClinicalTrials.gov/show/NCT00689078 Completed ORA, Inc. 2008-06-30
NCT00671268 Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma https://ClinicalTrials.gov/show/NCT00671268 Completed Allergopharma GmbH & Co. KG 2012-03-31
NCT00655109 A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00655109 Completed Greiner, Jack V., OD DO PhD 2008-03-31
NCT00652223 Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy https://ClinicalTrials.gov/show/NCT00652223 Completed Cytos Biotechnology AG NA
NCT00623701 Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation https://ClinicalTrials.gov/show/NCT00623701 Completed Allergopharma GmbH & Co. KG 2011-10-31
NCT00622908 Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00622908 Completed Bausch & Lomb Incorporated 2005-06-30
NCT00609128 Effect of Olopatadine on Allergic Tear Mediators https://ClinicalTrials.gov/show/NCT00609128 Completed University of Wisconsin, Madison 2009-11-30
NCT00800332 Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy https://ClinicalTrials.gov/show/NCT00800332 Completed Cytos Biotechnology AG 2010-04-30
NCT00586664 Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00586664 Completed Bausch & Lomb Incorporated 2008-06-30
NCT00586625 Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers https://ClinicalTrials.gov/show/NCT00586625 Completed Bausch & Lomb Incorporated 2008-05-31
NCT00581542 Moxifloxacin vs. Polytrim for Conjunctivitis https://ClinicalTrials.gov/show/NCT00581542 Completed University of Rochester 2009-03-31
NCT00578955 Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis https://ClinicalTrials.gov/show/NCT00578955 Completed InSite Vision 2008-10-31
NCT00574704 A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT00574704 Completed Cytos Biotechnology AG 2008-03-31
NCT00574379 Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR https://ClinicalTrials.gov/show/NCT00574379 Completed Faes Farma, S.A. 2008-03-31
NCT00574223 A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT00574223 Completed Cytos Biotechnology AG 2009-03-31
NCT00569777 Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers https://ClinicalTrials.gov/show/NCT00569777 Completed Vistakon Pharmaceuticals 2008-02-29
NCT00567918 Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis https://ClinicalTrials.gov/show/NCT00567918 Completed Astellas Pharma Inc 2008-01-31
NCT00567762 Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis https://ClinicalTrials.gov/show/NCT00567762 Completed Astellas Pharma Inc NA
NCT00567346 Efficacy and Safety of Grass Pollen Sublingual Immunotherapy https://ClinicalTrials.gov/show/NCT00567346 Completed Artu Biologicals 2007-10-31
NCT00565123 Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00565123 Completed Laser Microsurgery Centre, Poland NA
NCT00562159 Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) https://ClinicalTrials.gov/show/NCT00562159 Completed ALK-Abelló A/S 2009-09-30
NCT00559546 Montelukast as a Controller of Atopic Syndrome https://ClinicalTrials.gov/show/NCT00559546 Completed University of Helsinki NA
NCT00550875 Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT00550875 Completed Laboratorios Leti, S.L. 2009-12-31
NCT00550550 Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) https://ClinicalTrials.gov/show/NCT00550550 Completed ALK-Abelló A/S 2009-09-30
NCT00540631 Multicenter Trial of Immunotherapy With House Dust Mite Allergoid https://ClinicalTrials.gov/show/NCT00540631 Completed Allergopharma GmbH & Co. KG 2010-08-31
NCT00537342 Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) https://ClinicalTrials.gov/show/NCT00537342 Completed Laboratorios Leti, S.L. 2009-09-30
NCT00534794 Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00534794 Completed Merck Sharp & Dohme Corp. 2008-01-31
NCT00518089 A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00518089 Completed Allergan 2009-01-31
NCT00509873 A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00509873 Completed Allergan 2008-06-30
NCT00501527 Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense https://ClinicalTrials.gov/show/NCT00501527 Completed Laboratorios Leti, S.L. 2009-10-31
NCT00464438 A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00464438 Completed Allergan 2008-09-30
NCT00445874 Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00445874 Completed Vistakon Pharmaceuticals NA
NCT00432757 Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00432757 Completed Vistakon Pharmaceuticals NA
NCT00424398 Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00424398 Completed Bausch & Lomb Incorporated 2007-07-31
NCT00423007 Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00423007 Completed Bausch & Lomb Incorporated 2007-08-31
NCT00422149 Twin SUBLIVAC® Grasses Clinical Efficacy Study https://ClinicalTrials.gov/show/NCT00422149 Completed HAL Allergy 2007-10-31
NCT00407589 Systemic Pharmacokinetics of BOL-303224-A https://ClinicalTrials.gov/show/NCT00407589 Completed Bausch & Lomb Incorporated 2007-10-31
NCT00389025 Mast-Cell Stabilizing Effects of Olopatadine https://ClinicalTrials.gov/show/NCT00389025 Completed Alcon Research 2007-04-30
NCT00367640 Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT00367640 Completed Stallergenes Greer 2005-09-30
NCT00364091 Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00364091 Completed Vistakon Pharmaceuticals 2006-10-31
NCT00357773 Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00357773 Completed Laboratoires Thea NA
NCT00348348 A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00348348 Completed Bausch & Lomb Incorporated 2007-07-31
NCT00347932 A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. https://ClinicalTrials.gov/show/NCT00347932 Completed Bausch & Lomb Incorporated 2007-11-30
NCT00332293 AL-15469A for the Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00332293 Completed Alcon Research 2006-12-31
NCT00331916 AL-15469A for the Treatment of Bacterial Conjunctivitis https://ClinicalTrials.gov/show/NCT00331916 Completed Alcon Research 2007-05-31
NCT00331500 Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00331500 Completed Alcon Research 2006-07-27
NCT00328653 Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) https://ClinicalTrials.gov/show/NCT00328653 Completed Santen SAS NA
NCT00312338 Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora https://ClinicalTrials.gov/show/NCT00312338 Completed Alcon Research 2007-06-30
NCT00311844 A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) https://ClinicalTrials.gov/show/NCT00311844 Completed Merck Sharp & Dohme Corp. 2005-05-28
NCT00266734 Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears https://ClinicalTrials.gov/show/NCT00266734 Completed Rapid Pathogen Screening NA
NCT00244543 Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00244543 Completed Vistakon Pharmaceuticals 2005-11-30
NCT00241319 Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00241319 Completed Vistakon Pharmaceuticals 2005-12-31
NCT00223951 Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers https://ClinicalTrials.gov/show/NCT00223951 Completed Vistakon Pharmaceuticals 2005-12-31
NCT00133627 Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT00133627 Completed Novartis 2005-10-31
NCT00798577 Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment https://ClinicalTrials.gov/show/NCT00798577 Completed Alcon Research 2009-02-28
NCT00105534 Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) https://ClinicalTrials.gov/show/NCT00105534 Completed Merck Sharp & Dohme Corp. 2006-01-31
NCT00105469 Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) https://ClinicalTrials.gov/show/NCT00105469 Completed Merck Sharp & Dohme Corp. 2005-10-31
NCT00818805 Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) https://ClinicalTrials.gov/show/NCT00818805 Completed Alcon Research 2008-07-31
NCT00818181 Open Label Safety Study of a Birch Pollen Allergen Extract https://ClinicalTrials.gov/show/NCT00818181 Completed Allergopharma GmbH & Co. KG 2009-02-28

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03356197 Epidemiology of Conjunctivitis in the Emergency Department https://ClinicalTrials.gov/show/NCT03356197 Completed Instituto de Olhos de Goiania 2017-09-03
NCT03101618 Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers https://ClinicalTrials.gov/show/NCT03101618 Completed Gachon University Gil Medical Center 2016-11-27
NCT03055065 ADenoVirus Initiative Study in Epidemiology in Italy https://ClinicalTrials.gov/show/NCT03055065 Completed NicOx 2015-10-31
NCT02555761 Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea https://ClinicalTrials.gov/show/NCT02555761 Completed Allergan 2018-03-19
NCT02295969 Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis https://ClinicalTrials.gov/show/NCT02295969 Completed Stallergenes Greer 2017-07-03
NCT02254330 ADenoVirus Initiative Study in Epidemiology in Spain https://ClinicalTrials.gov/show/NCT02254330 Completed NicOx 2015-08-31
NCT02112773 ADenoVirus Initiative Study in Epidemiology in UK https://ClinicalTrials.gov/show/NCT02112773 Completed NicOx 2015-06-30
NCT02054273 ADenoVirus Initiative Study in Epidemiology in Germany https://ClinicalTrials.gov/show/NCT02054273 Completed NicOx 2015-06-30
NCT02054234 ADenoVirus Initiative Study in Epidemiology in France https://ClinicalTrials.gov/show/NCT02054234 Completed NicOx 2014-12-31
NCT01987765 Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea https://ClinicalTrials.gov/show/NCT01987765 Completed Allergan 2012-09-30
NCT01949428 House Dust Mite Observational Study https://ClinicalTrials.gov/show/NCT01949428 Completed Circassia Limited 2014-03-31
NCT01949415 An Optional Investigation of Biomarkers of Efficacy https://ClinicalTrials.gov/show/NCT01949415 Completed Circassia Limited 2014-04-30
NCT01686048 The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel https://ClinicalTrials.gov/show/NCT01686048 Completed Meir Medical Center 2015-04-30
NCT01679015 Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes https://ClinicalTrials.gov/show/NCT01679015 Completed Schwartz Laser Eye Center 2014-02-28
NCT01535118 A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) https://ClinicalTrials.gov/show/NCT01535118 Completed ALK-Abelló A/S 2012-05-31
NCT01486498 Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy https://ClinicalTrials.gov/show/NCT01486498 Completed Aalborg University 2009-11-30
NCT01339507 A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft https://ClinicalTrials.gov/show/NCT01339507 Completed Cunningham, Derek N., O.D., P.A. 2011-05-31
NCT04389034 Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels https://ClinicalTrials.gov/show/NCT04389034 Recruiting Allergy Therapeutics 2020-10-31
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374656 Recruiting Johns Hopkins University 2021-05-31
NCT04276623 Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment https://ClinicalTrials.gov/show/NCT04276623 Recruiting UMC Utrecht 2022-09-01
NCT03861910 Dietary Choice for the Management of Cow’s Milk Allergy Influences Other Allergic Manifestations https://ClinicalTrials.gov/show/NCT03861910 Recruiting Federico II University 2020-05-31
NCT03812952 China Red Eye Study on Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT03812952 Active, not recruiting Sun Yat-sen University 2019-12-31
NCT03753893 Ocular Manifestations in Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03753893 Active, not recruiting Lawson Health Research Institute 2020-10-01
NCT03528915 Prevalence of Conjunctivitis and Indentification of Risk Factors With and Without Prophylactic Antibiotic Treatment in Neonates https://ClinicalTrials.gov/show/NCT03528915 Completed Centre Hospitalier Universitaire, Amiens 2016-05-12
NCT00985075 A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube https://ClinicalTrials.gov/show/NCT00985075 Completed ORA, Inc. 2009-06-30
NCT00982163 A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season https://ClinicalTrials.gov/show/NCT00982163 Completed ORA, Inc. 2008-09-30
NCT03821077 Study to Evaluate the Efficacy and Safety of “Allergovac Poliplus” in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma https://ClinicalTrials.gov/show/NCT03821077 Active, not recruiting Roxall Medicina España S.A 2021-06-30
NCT02844842 Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice https://ClinicalTrials.gov/show/NCT02844842 Completed Roxall Medicina España S.A 2018-09-06
NCT04299399 Corneal Biomechanical Changes of Allergic Conjunctivitis https://ClinicalTrials.gov/show/NCT04299399 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2021-05-31
NCT00522600 Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations https://ClinicalTrials.gov/show/NCT00522600 Completed Robin, Alan L., M.D. NA
NCT00008541 Evaluation and Treatment of Patients With Corneal and External Diseases https://ClinicalTrials.gov/show/NCT00008541 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001734 Screening for NEI Clinical Studies https://ClinicalTrials.gov/show/NCT00001734 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02488447 Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT02488447 Completed Roxall Medicina España S.A 2017-05-25
NCT03652415 DRy Eye Outcome and Prescription Study https://ClinicalTrials.gov/show/NCT03652415 Recruiting Guy’s and St Thomas’ NHS Foundation Trust 2021-08-23